|
⚲
|
| Afferent Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001476010 |
| Sale | 2009-12-09 ($23.0 M Offered, $3.0 M Sold) |
| Fund | |
| Phone | 6175852000 |
| Address | c/o Third Rock Ventures, LP Boston, 02116 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Kevin Starr | |
| David Neafus | |
| Arthur Pappas | |
| Jesse Treu | |
| Liam Ratcliffe | |
| Mitchell Bloom |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Starwood Distressed Opportunity Fund XIII Global, L.P.
✚
|
0.0 | |
|
Stasys Medical Corp.
✚
|
0.0 | |
|
Stateful Capital Fund 1 LP
✚
|
0.0 | |
|
State Industrial Participation Co
✚
|
0.0 | |
|
Station Place Holdings LLC
✚
|
0.0 | |
|
St Clair Gregory SR
✚
|
0.0 | |
|
Steiner Gregory L.
✚
|
0.0 | |
|
Stonegate Surgery Center, L.P.
✚
|
0.0 | |
|
Stonehenge Technology Labs, Inc.
✚
|
0.0 | |
|
Starrett Douglas A
✚
|
0.0 |